Institutional investors purchased a net $73.9 thousand shares of GHDX during the quarter ended June 2016, and now own 90.61% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 270.4 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 254.9 Thousand shares of Genomic Health Inc
GHOST TREE CAPITAL LLC Bought 200.0 Thousand shares of Genomic Health Inc